{"denomUnitsSelected":"Participants","description":"Determine genomic signatures associated with response and clinical benefit of the combination of letrozole + Ribociclib","reportingStatus":"NOT_POSTED","timeFrame":"At time of primary and secondary outcome analysis up to 5 years","title":"Mutation Analysis of Genomic Signatures","type":"OTHER_PRE_SPECIFIED"}